Scott V. Bratman
University of Toronto, University Health Network, Princess Margaret Cancer Centre
Papers
4
Total Citations
58
H-Index
4
About
Scott V. Bratman is a leading radiation oncologist and researcher whose work centers on the integration of advanced surgical techniques with precision radiotherapy to transform the management of head and neck cancers, particularly carcinomas of unknown primary (CUP). His major contributions lie in pioneering a paradigm shift away from the historical standard of comprehensive, high-volume pharyngeal and bilateral neck irradiation. Instead, Bratman has championed a de-intensification strategy that leverages transoral robotic surgery (TORS) to precisely locate hidden primary tumors. By using TORS to identify the primary site, his research enables a dramatic reduction in radiotherapy treatment volumes, thereby minimizing debilitating side effects without compromising oncologic control. This approach is codified in his landmark FIND clinical trial protocol, which has garnered over 30 citations and established a new framework for tailored treatment. His work has shown that for patients with p16-positive, unknown primary squamous cell carcinoma, TORS-guided volume de-intensification is both safe and effective, representing a significant leap forward in functional preservation. With a portfolio of highly cited papers, including a seminal 2016 study on head and neck CUP outcomes, Bratman’s research is reshaping clinical guidelines and offering patients a less toxic, more targeted path to cure.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4